Last updated: January 15, 2025
Sponsor: National and Kapodistrian University of Athens
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Supplemental oxygen therapy
Clinical Study ID
NCT06780813
834/24
Ages 18-85 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Obese (BMI>30kg/m2) gynecological cancer patients
Optimized preoperative CBC values (hemoglobin >11g/dl, WBC 4.000-11.000 X 109/L,platelets 150,000 to 400,000 X 109/L)
In the case of neoadjuvant therapy an interval longer than three weeks between thelast cycle and the operation
Exclusion
Exclusion Criteria:
Active immunosuppresion
Preexisting infection of the abdominal wall
Preexisting sepsis
Study Design
Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Supplemental oxygen therapy
Phase:
Study Start date:
January 10, 2025
Estimated Completion Date:
May 01, 2026
Study Description
Connect with a study center
First department of Obstetrics and Gynecology
Athens, 11528
GreeceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.